Incyte generated $5.4B in trailing twelve-month revenue, up 0.2% year-over-year. Net income was $1.4B with a 26.71% net margin. Gross margin stands at 92.47% and operating margin at 30.05%. Diluted EPS is $7.08, which grew 27.3% year-over-year. Based on the Q1 2026 filing.